Bluestar Adisseo Co (600299)

Currency in CNY
10.24
-0.09(-0.87%)
Delayed Data·
600299 Scorecard
Full Analysis
Has a perfect Piotroski Score of 9
600299 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10.2210.38
52 wk Range
9.2012.85
Key Statistics
Bid/Ask
10.23 / 10.24
Prev. Close
10.33
Open
10.38
Day's Range
10.22-10.38
52 wk Range
9.2-12.85
Volume
4.86M
Average Volume (3m)
7.24M
1-Year Change
-6.45%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600299 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
11.45
Upside
+11.78%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Bluestar Adisseo Co News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Bluestar Adisseo Co Company Profile

Bluestar Adisseo Company engages in the research, development, production, and sale of feed additives for animal nutrition worldwide. The company offers Rhodimet, a methionine solution for animals, including Rhodimet AT88 and Rhodimet NP99; Smartamine and MetaSmart for proper balance of amino acid; AdiSodium, a feed material for monogastrics and ruminants; Microvit, a vitamin additives in animal nutrition; Krave AP stimulate appetite and feed intake during lactation; Optisweet, a feed sweetener to stimulate early feed intake; Gusti Plus improves the palatability of feeds and supplements; Maxamore provides feed with aroma and uniform taste; and Delistart, a combination of flavorings, appetizing substances, and sweeteners for piglets and calves. It also provides Rovabio Excel, a feed additive containing a combination of 19 active enzymes; Rovabio Advance, a feedase to improve the digestibility of all feed nutrients; Rovabio Advance PHY, multi-enzymatic solution for overall feed digestibility; Rovabio PhyPlus, a phytase solution; RA LeciMax, a feed additive that improves FCR and ADWG; Selisseo, a hydroxy- selenomethionine for stress resistance; Apex 5 enhances botanical booster; Alterion, a probiotic solution; Adimix Precision, precision delivery coated sodium butyrate; FRA Butyrin, for healthy intestinal environment comprising FRA Butyrin Hybrid and Ultra; FRA C12, a solution to reduce the usage of antibiotic growth promotors in animal production; and FRA Gut Balance for pathogen control. In addition, the company offers Unike Plus, Unike, Toxy-Nil for mycotoxin management; Oxy-Nil, an antioxidant program; and aquaculture specialties products, including Aqualyso, Lipogest, Sanacore GM, Bacti-Nil Aqua, and Apex Branchia. Further, it provides services, including PNE, Nestor, Asict, DIM, E.Lab, and MycoMan. The company was founded in 1939 and is based in Beijing, China. Bluestar Adisseo Company is a subsidiary of China National Bluestar (Group) Co., Ltd.

Employees
2929
Market
China

Compare 600299 to Peers and Sector

Metrics to compare
600299
Peers
Sector
Relationship
P/E Ratio
19.9x30.7x2.7x
PEG Ratio
0.060.110.00
Price/Book
1.7x2.2x1.6x
Price / LTM Sales
1.7x2.1x1.3x
Upside (Analyst Target)
5.8%16.7%18.5%
Fair Value Upside
Unlock1.3%0.9%Unlock

Analyst Ratings

4 Buy
0 Hold
1 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 11.45
(+11.78% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.52%
Dividend Yield
2.32%
Industry Median 1.54%
Annualised payout
0.24
Paid unevenly
5-Years Growth
-7.02%
Growth Streak

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
0.1746 / --
Revenue / Forecast
4.30B / --
EPS Revisions
Last 90 days

600299 Income Statement

FAQ

What Stock Exchange Does Bluestar Adisseo Trade On?

Bluestar Adisseo is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Bluestar Adisseo?

The stock symbol for Bluestar Adisseo is "600299."

What Is the Bluestar Adisseo Market Cap?

As of today, Bluestar Adisseo market cap is 27.46B.

What Is Bluestar Adisseo's Earnings Per Share (TTM)?

The Bluestar Adisseo EPS (TTM) is 0.52.

When Is the Next Bluestar Adisseo Earnings Date?

Bluestar Adisseo will release its next earnings report on 29 Aug 2025.

From a Technical Analysis Perspective, Is 600299 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Bluestar Adisseo Stock Split?

Bluestar Adisseo has split 3 times.

How Many Employees Does Bluestar Adisseo Have?

Bluestar Adisseo has 2929 employees.

What is the current trading status of Bluestar Adisseo (600299)?

As of 23 Jul 2025, Bluestar Adisseo (600299) is trading at a price of 10.24, with a previous close of 10.33. The stock has fluctuated within a day range of 10.22 to 10.38, while its 52-week range spans from 9.20 to 12.85.

What Is Bluestar Adisseo (600299) Price Target According to Analysts?

The average 12-month price target for Bluestar Adisseo is CNY11.44667, with a high estimate of CNY15.41 and a low estimate of CNY8. 4 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +11.78% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.